Banque de Luxembourg Investments (BLI)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Sell
923
-80
-8% -$27.4K 0.01% 165
2026
Q1
$324K Hold
1,003
– – 0.01% 163
2025
Q4
$330K Sell
1,003
-4,080
-80% -$1.29M 0.01% 166
2025
Q3
$1.39M Sell
5,083
-2,700
-35% -$783K 0.04% 155
2025
Q2
$2.16M Hold
7,783
– – 0.06% 157
2025
Q1
$2.38M Sell
7,783
-700
-8% -$207K 0.07% 116
2024
Q4
$2.2M Buy
+8,483
New +$2.52M 0.06% 117

Other funds holding AMGN

Banque de Luxembourg Investments (BLI)'s AMGN Position: Q2 2026 in Review

Banque de Luxembourg Investments (BLI) reduced its Amgen (AMGN) stake by 8% in Q2 2026, selling an estimated $27.4K and leaving 923 shares worth $334K. The position accounts for 0.01% of the portfolio, ranked #165.

Banque de Luxembourg Investments (BLI) first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.38M in Q1 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Banque de Luxembourg Investments (BLI) held 923 shares of Amgen worth $334K as of Q2 2026.
  • Banque de Luxembourg Investments (BLI) sold 80 Amgen shares in Q2 2026, an estimated $27.4K.
  • Amgen made up 0.01% of Banque de Luxembourg Investments (BLI)'s portfolio in Q2 2026, its #165 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Banque de Luxembourg Investments (BLI)'s Amgen position peaked at $2.38M in Q1 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q2 2026, filed 10 Aug 2026.